Cipher Pharmaceuticals Inc.
TSX:CPH.TO
Overview | Financials
Company Name | Cipher Pharmaceuticals Inc. |
Symbol | CPH.TO |
Currency | CAD |
Price | 15.55 |
Market Cap | 397,907,395 |
Dividend Yield | 0% |
52-week-range | 4.3 - 19.69 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Craig J. Mull |
Website | https://www.cipherpharma.com |
An error occurred while fetching data.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD